An arginase inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Arginase Inhibitor 1

Item No. 28418

Technical Information
Formal Name
(αR)-α-amino-α-(4-boronobutyl)-1-piperidinebutanoic acid
CAS Number
1345808-25-4
Molecular Formula
C13H27BN2O4
Formula Weight
Purity
≥90%
Formulation
A solid
DMSO: 50 mg/mlWater: 30 mg/ml
SMILES
OB(O)CCCC[C@@](C(O)=O)(N)CCN1CCCCC1
InChi Code
InChI=1S/C13H27BN2O4/c15-13(12(17)18,6-2-3-8-14(19)20)7-11-16-9-4-1-5-10-16/h19-20H,1-11,15H2,(H,17,18)/t13-/m1/s1
InChi Key
CHPILBYRQPOXMV-CYBMUJFWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Arginase inhibitor 1 is an inhibitor of arginase I and II (IC50s = 223 and 509 nM, respectively, for the recombinant human enzymes).1 It decreases arginase I activity in CHOK cells expressing human arginase I (IC50 = 8 µM). Arginase inhibitor 1 (100 mg/kg, i.v.) reduces infarct size in a rat model of myocardial ischemia and reperfusion injury induced by left-main coronary artery occlusion.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Van Zandt, M.C., Whitehouse, D.L., Golebiowski, A., et alDiscovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury. J. Med. Chem. 56(6), 2568-2580 (2013).